Phase 4 Major Depressive Disorder trials recruiting now
All Major Depressive Disorder trials, every phase
12
Phase 4 recruiting
Other phases for Major Depressive Disorder
Phase 4 Major Depressive Disorder trials
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Aβ Dynamics in LLMD
- Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
- Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
- Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
- Neural Circuit Effects of Ketamine in Depression
- Non-invasive BCI and Application Verification for Depressed People
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
- Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
- Personalized Indications for CBT and Antidepressants in Treating Depression
- Positioning of Esketamine Treatment in the Real-world Management of Depression
Common questions
What does Phase 4 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.